Literature DB >> 7884219

Hepatitis C virus infection in sexually active homosexual men.

S P Buchbinder1, M H Katz, N A Hessol, J Liu, P M O'Malley, M J Alter.   

Abstract

While hepatitis C virus (HCV) is known to be transmitted parenterally, the role of sexual transmission remains unclear. In order to examine the association of sexual risk factors with HCV seroprevalence at a time when unprotected sexual practices were still quite common, 435 homosexual men recruited from a municipal sexually transmitted disease clinic with behavioural data and serologic specimens from 1983-1984 were evaluated. Overall, 25% of men reporting injecting drug use (IDU) and 5% of men with no IDU were anti-HCV positive; the rate in the non-IDU was significantly higher than age-matched rates in blood donors (summary odds ratio 3.5, 95% confidence interval 2.8-4.2). In addition to IDU, amphetamine and phencyclidine use were also associated with anti-HCV positivity on univariate analysis. Sexual risk factors for anti-HCV positivity included anal receptive intercourse, 'fisting', having an IDU sexual partner, a self-reported history of genital herpes and HIV seropositivity. On multivariate analysis, only IDU was significantly associated with anti-HCV positivity. Thus, sexual practices appear to play a minor role in transmission of HCV.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7884219     DOI: 10.1016/s0163-4453(94)91128-2

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  8 in total

1.  Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behaviour.

Authors:  N J Bodsworth; P Cunningham; J Kaldor; B Donovan
Journal:  Genitourin Med       Date:  1996-04

2.  Lack of evidence of sexual transmission of hepatitis C virus in a prospective cohort study of men who have sex with men.

Authors:  Michel Alary; Jean R Joly; Jean Vincelette; René Lavoie; Bruno Turmel; Robert S Remis
Journal:  Am J Public Health       Date:  2005-03       Impact factor: 9.308

Review 3.  Hepatitis C virus infection in HIV-infected patients.

Authors:  Mark S Sulkowski
Journal:  Curr HIV/AIDS Rep       Date:  2004-09       Impact factor: 5.071

4.  Wide range of quasispecies diversity during primary hepatitis C virus infection.

Authors:  Belinda L Herring; Rose Tsui; Lorraine Peddada; Michael Busch; Eric L Delwart
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 5.  HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms.

Authors:  Lynn E Taylor; Tracy Swan; Kenneth H Mayer
Journal:  Clin Infect Dis       Date:  2012-07       Impact factor: 9.079

6.  Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection.

Authors:  C Brander; K E Hartman; A K Trocha; N G Jones; R P Johnson; B Korber; P Wentworth; S P Buchbinder; S Wolinsky; B D Walker; S A Kalams
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

7.  Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new host.

Authors:  Richard J P Brown; Natalia Hudson; Garrick Wilson; Shafiq Ur Rehman; Sara Jabbari; Ke Hu; Alexander W Tarr; Persephone Borrow; Michael Joyce; Jamie Lewis; Lin Fu Zhu; Mansun Law; Norman Kneteman; D Lorne Tyrrell; Jane A McKeating; Jonathan K Ball
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

8.  Sexually Transmitted Diseases in Men Who Have Sex with Men: A Clinical Review.

Authors:  Jeffrey D. Klausner; William Wong
Journal:  Curr Infect Dis Rep       Date:  2003-04       Impact factor: 3.663

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.